Zobrazeno 1 - 10
of 227
pro vyhledávání: '"Rupert Bauersachs"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 532-549 (2020)
Abstract Cancer‐associated venous thromboembolism (VTE) is a frequent, potentially life‐threatening event that complicates cancer management. Anticoagulants are the cornerstone of therapy for the treatment and prevention of cancer‐associated th
Externí odkaz:
https://doaj.org/article/3660c3334ebf4d9d85337c74edd219e0
Autor:
Cecilia Becattini, Rupert Bauersachs, Giorgio Maraziti, Laurent Bertoletti, Alexander Cohen, Jean M. Connors, Dario Manfellotto, Antonio Sanchez, Benjamin Brenner, Giancarlo Agnelli
Publikováno v:
Haematologica, Vol 107, Iss 7 (2021)
The effect of renal impairment (RI) on risk of bleeding and recurrent thrombosis in cancer patients treated with direct oral anticoagulants for venous thromboembolism (VTE) is undefined. We ran a prespecified analysis of the randomized Caravaggio stu
Externí odkaz:
https://doaj.org/article/12bf20b00dd04b7f8aabc3aaaaaa5288
Autor:
Rupert Bauersachs, Olivia Wu, Neil Hawkins, Kevin Bowrin, Piotr Wojciechowski, Emilie Clay, Maria Huelsebeck
Publikováno v:
Cardiovascular Therapeutics, Vol 2021 (2021)
Background. The guidelines on antithrombotic treatment in patients with symptomatic peripheral artery disease (PAD) undergoing peripheral revascularization of the lower extremities were developed based on heterogeneous trials, assessing various dose
Externí odkaz:
https://doaj.org/article/ed4f966f29ea426191aa307c4490e39d
Autor:
Rupert Bauersachs, Olivia Wu, Jean-Baptiste Briere, Kevin Bowrin, Katarzyna Borkowska, Anna Jakubowska, Vanessa Taieb, Mondher Toumi, Maria Huelsebeck
Publikováno v:
Cardiovascular Therapeutics, Vol 2020 (2020)
Aims. Acetylsalicylic acid (ASA) is widely used for the prevention of atherothrombotic events in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD), but the risk of vascular events remains high. We aimed at identi
Externí odkaz:
https://doaj.org/article/0e9c997f5b3640919ca68eb1c4468e08
Autor:
Rupert Bauersachs, Uwe Zeymer, Jean-Baptiste Brière, Caroline Marre, Kevin Bowrin, Maria Huelsebeck
Publikováno v:
Cardiovascular Therapeutics, Vol 2019 (2019)
Background. Atherothrombotic disease, including coronary artery disease (CAD) and peripheral artery disease (PAD), can lead to cardiovascular (CV) events, such as myocardial infarction, stroke, limb ischemia, heart failure, and CV death. Aim. Evaluat
Externí odkaz:
https://doaj.org/article/78312963b30e47649bbc3d4ae543ad1c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maria Cristina Vedovati, Michela Giustozzi, Andrés Munoz, Laurent Bertoletti, Alexander T. Cohen, Frederikus A. Klok, Jean M. Connors, Rupert Bauersachs, Benjamin Brenner, Mauro Campanini, Cecilia Becattini, Giancarlo Agnelli
Publikováno v:
European Journal of Internal Medicine. 112:29-36
Autor:
Holger Reinecke, Christiane Engelbertz, Rupert Bauersachs, Günter Breithardt, Hans-Herbert Echterhoff, Joachim Gerß, Karl Georg Haeusler, Bernd Hewing, Joachim Hoyer, Sabine Juergensmeyer, Thomas Klingenheben, Guido Knapp, Lars Christian Rump, Hans Schmidt-Guertler, Christoph Wanner, Paulus Kirchhof, Dennis Goerlich
Publikováno v:
Circulation. 147:296-309
Background: Non–vitamin K oral anticoagulants have become the standard therapy for preventing stroke and ischemic thromboembolism in most patients with atrial fibrillation (AF). The effectiveness and safety of non–vitamin K oral anticoagulants in
Autor:
Florian, Langer, Horst E, Gerlach, Alexandra, Schimke, Andreas, Heinken, Ulrich, Hoffmann, Thomas, Noppeney, David, Pittrow, Jens, Klotsche, Eberhard, Rabe, Rupert, Bauersachs
Publikováno v:
Thrombosis Research. 220:145-152
Autor:
Rupert Bauersachs
Publikováno v:
Aktuelle Kardiologie. 11:543-550
ZusammenfassungIn diesem Artikel werden aktuelle Evidenz und Leitlinienempfehlungen zur Antikoagulation (AK) bei tiefer Venenthrombose (TVT) und Lungenembolie (LE) zusammengefasst. Bei LE leitet die Stratifizierung bezüglich Frühletalität das weit